New Target in Sepsis: The Host Response

Researchers from Harvard University's Center for Experimental Therapeutics and Reperfusion Injury reported that bioactive lipid molecules referred to as 13-series resolvins (RvTs) hastened the resolution of inflammation and increased survival from Escherichia coli infections in a mouse model. http://www.medpagetoday.com/InfectiousDisease/GeneralInfectiousDisease/54884?xid=nl_mpt_DHE_2015-11-27&eun=g721819d0r